212 related articles for article (PubMed ID: 33099392)
1. The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes F; Dutronc Y; Mesinkovska NA; Ko JM; King BA
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S71-S77. PubMed ID: 33099392
[TBL] [Abstract][Full Text] [Related]
2. A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Macey J; Kitchen H; Aldhouse NVJ; Edson-Heredia E; Burge R; Prakash A; King BA; Mesinkovska N
Br J Dermatol; 2022 May; 186(5):849-860. PubMed ID: 34811721
[TBL] [Abstract][Full Text] [Related]
3. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
[TBL] [Abstract][Full Text] [Related]
4. Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.
Macey J; Kitchen H; Aldhouse NVJ; Burge RT; Edson-Heredia E; McCollam JS; Isaka Y; Torisu-Itakura H
Dermatol Ther (Heidelb); 2021 Apr; 11(2):433-447. PubMed ID: 33464474
[TBL] [Abstract][Full Text] [Related]
5. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
[TBL] [Abstract][Full Text] [Related]
6. Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Mesinkovska N; Ko JM; King BA
Qual Life Res; 2023 May; 32(5):1319-1327. PubMed ID: 35821174
[TBL] [Abstract][Full Text] [Related]
7. Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Br J Dermatol; 2020 Dec; 183(6):1065-1072. PubMed ID: 32163589
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study.
Majid I; Sameem F; Sultan J; Aleem S
J Cosmet Dermatol; 2021 Aug; 20(8):2565-2570. PubMed ID: 34129730
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey.
Bewley A; Figueras-Nart I; Zhang J; Guerreiro M; Tietz N; Chtourou S; Durand F; Blume-Peytavi U
Clin Cosmet Investig Dermatol; 2024; 17():751-761. PubMed ID: 38566887
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials.
Ko JM; Mayo TT; Bergfeld WF; Dutronc Y; Yu G; Ball SG; Somani N; Craiglow BG
JAMA Dermatol; 2023 Sep; 159(9):970-976. PubMed ID: 37556146
[TBL] [Abstract][Full Text] [Related]
11. Estimation of health utility values for alopecia areata.
Aggio D; Dixon C; Law EH; Randall R; Price T; Lloyd A
Qual Life Res; 2024 Jun; 33(6):1581-1592. PubMed ID: 38551802
[TBL] [Abstract][Full Text] [Related]
12. Eyebrows Are Important in the Treatment of Alopecia Areata.
Liu LY; King BA; Ko JM
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S37-S40. PubMed ID: 33099382
[TBL] [Abstract][Full Text] [Related]
13. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
; Moussa A; Bennett M; Wall D; Meah N; York K; Bokhari L; Asfour L; Rees H; Abraham LS; Asz-Sigall D; Basmanav FB; Bergfeld W; Betz RC; Bhoyrul B; Blume-Peytavi U; Callender V; Chitreddy V; Combalia A; Cotsarelis G; Craiglow B; Dhurat R; Donovan J; Doroshkevich A; Eisman S; Farrant P; Ferrando J; Gadzhigoroeva A; Green J; Grimalt R; Harries M; Hordinsky M; Irvine A; Jolliffe V; Kaiumov S; King B; Lee J; Lee WS; Li J; Lortkipanidze N; McMichael A; Mesinkovska NA; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Rudnicka L; Corralo DS; Senna M; Shapiro J; Sharma P; Siliuk T; Starace M; Suchonwanit P; Takwale A; Tosti A; Vañó-Galván S; Visser WI; Vogt A; Wade M; Yip L; Zhou C; Sinclair R
JAMA Dermatol; 2024 Mar; 160(3):341-350. PubMed ID: 38324292
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata.
Gelhorn HL; Cutts K; Edson-Heredia E; Wright P; Delozier A; Shapiro J; Senna M; Tosti A
Dermatol Ther (Heidelb); 2022 Apr; 12(4):989-997. PubMed ID: 35352323
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split-face comparative study.
Choe SJ; Lee WS
Int J Dermatol; 2017 Feb; 56(2):184-189. PubMed ID: 28074525
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata: Clinical presentation, diagnosis, and unusual cases.
Finner AM
Dermatol Ther; 2011; 24(3):348-54. PubMed ID: 21689244
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial impact of pediatric alopecia areata: A survey study.
Benton S; Bellefeuille G; Rypka K; Nguyen A; Raymond O; Gorbatenko-Roth K; Maguiness S; Hordinsky MK
Pediatr Dermatol; 2023 Mar; 40(2):312-314. PubMed ID: 36722625
[TBL] [Abstract][Full Text] [Related]
18. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
19. The value of dermoscopy in diagnosing eyebrow loss in patients with alopecia areata and frontal fibrosing alopecia.
Waśkiel-Burnat A; Rakowska A; Kurzeja M; Czuwara J; Sikora M; Olszewska M; Rudnicka L
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):213-219. PubMed ID: 30290016
[TBL] [Abstract][Full Text] [Related]
20. Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Renert-Yuval Y; Correa da Rosa J; Garcet S; Pavel AB; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Krueger JG; Guttman-Yassky E
Br J Dermatol; 2022 Oct; 187(4):539-547. PubMed ID: 35656793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
